Viking Therapeutics' leading candidate posted strong mid-stage data and is undergoing phase 3 studies. Though there are some risks, the stock could soar if it can pass the upcoming clinical and ...
Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common ...
Health Secretary Robert F. Kennedy Jr. has spent years campaigning against vaccines, but with the flu shot, he’s suggested it’s personal. Kennedy has linked his strained, raspy speech to the vaccine, ...
The Food and Drug Administration's decision, made public on Feb. 10, 2026, to not review an application to approve Moderna's proposed mRNA-based flu vaccine set off a firestorm of criticism from ...
Ana Santos Rutschman does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...
The Food and Drug Administration rattled the biotech industry last week when it said it wouldn't even look at Moderna's application to market the first mRNA flu shot. But on Wednesday, the agency ...
Add Yahoo as a preferred source to see more of our stories on Google. The FDA's decision this week to reverse course and review Moderna's seasonal flu vaccine application followed a meeting in which ...
WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of ...
Read full article: West Bloomfield School District releases update after attack at Jewish temple Everything we know about a March 12, 2026, crash and shooting at Temple Israel in West Bloomfield ...
Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...
The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results